Opioid Receptors - Pharmacology
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Opioid receptor subtypes: fact or artifact? - British Journal of Anaesthesia
Understanding opioids in veterinary medicine
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
Receptor binding affinity of traditional mu-opioid agonists (morphine... | Download Table
Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Mu Opiate Receptor Agonist - an overview | ScienceDirect Topics
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | PLOS ONE
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design | Scientific Reports
Noribogaine is a G-protein biased κ-opioid receptor agonist - ScienceDirect
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking | PLOS ONE
Chemical structures of 'affinity-dominant' and 'efficacy-dominant' G... | Download Scientific Diagram
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
